Novel regulatory variant in ABO intronic RUNX1 binding site inducing A3 phenotype
- 16 January 2024
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 119 (4) , 377-382
Abstract
Background and Objectives: Mixed‐field agglutination in ABO phenotyping (A3, B3) has been linked to genetically different blood cell populations such as in chimerism, or to rare variants in either ABO exon 7 or regulatory regions. Clarification of such cases is challenging and would greatly benefit from sequencing technologies that allow resolving full‐gene haplotypes at high resolution.Materials and Methods: We used long‐read sequencing by Oxford Nanopore Technologies to sequence the entire ABO gene, amplified in two overlapping long‐range PCR fragments, in a blood donor presented with A3B phenotype. Confirmation analyses were carried out by Sanger sequencing and included samples from other family members.Results: Our data revealed a novel heterozygous g.10924C>A variant on the ABO*A allele located in the transcription factor binding site for RUNX1 in intron 1 (+5.8 kb site). Inheritance was shown by the results of the donor's mother, who shared the novel variant and the anti‐A specific mixed‐field agglutination.Conclusion: We discovered a regulatory variant in the 8‐bp RUNX1 motif of ABO, which extends current knowledge of three other variants affecting the same motif and also leading to A3 or B3 phenotypes. Overall, long‐range PCR combined with nanopore sequencing proved powerful and showed great potential as an emerging strategy for resolving cases with cryptic ABO phenotypes.Keywords
All Related Versions
This publication has 13 references indexed in Scilit:
- Human ABO gene transcriptional regulationTransfusion, 2020
- ABO genotyping with next‐generation sequencing to resolve heterogeneity in donors with serology discrepanciesTransfusion, 2018
- Blood group B gene is barely expressed inin vitroerythroid culture of Bm‐derived CD34+cells without an erythroid cell‐specific regulatory elementVox Sanguinis, 2014
- Presence of nucleotide substitutions in transcriptional regulatory elements such as the erythroid cell‐specific enhancer‐like element and theABOpromoter in individuals with phenotypes A3and B3, respectivelyVox Sanguinis, 2014
- Deletion of the RUNX1 binding site in the erythroid cell‐specific regulatory element of the ABO gene in two individuals with the Am phenotypeVox Sanguinis, 2013
- Expression of ABO blood-group genes is dependent upon an erythroid cell–specific regulatory element that is deleted in persons with the Bm phenotypeBlood, 2012
- Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancerNucleic Acids Research, 2010
- Many genetically defined ABO subgroups exhibit characteristic flow cytometric patternsTransfusion, 2010
- Blood group chimerism in human multiple births is not rareAmerican Journal of Medical Genetics, 1996
- Mosaicism of red cell ABO type without recognizable causeRevue Française de Transfusion et Immuno-hématologie, 1980